WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , 

ISSN 2457-0400

Impact Factor  :  6.711

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR April 2024 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

  • .

    6th INTERNATIONAL CONFERENCE ON EDUCATIONAL TECHNOLOGY AND CURRICULUM STUDIES(ICETC2019) 

     

    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased to 6.711 for Year 2024.

  • WJAHR: APRIL ISSUE PUBLISHED

    APRIL 2024 Issue has been successfully launched on APRIL 2024.

Best Paper Awards

World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

PREVALENCE OF HEPATITIS B AND C VIRUSES AMONG HAEMODIALYSIS PATIENTS IN NINAWA AT NORTH OF IRAQ DURING 2020

Maree Hasan Fatthi*, Rabee Abdalghafoor Mohamad and Mohammed Assi Jasim

ABSTRACT

Background: viral hepatitis B & C are regarded a great health problem all over the world as these infections may lead to chronic illness causing liver cirrhosis, hepatocellular carcinoma & liver failure. The infections with hepatitis B virus and hepatitis C virus are considered as the most common blood-borne infections in subjects on regular haemodialysis, therefore this study done to see the prevalence of hepatitis B and C viruses among haemodialysis patients in Ninawa at north of Iraq for the year 2020. Methods: This is a cross sectional study which was carried out on haemodialysis patients in the dialysis unit at Ibn-seena teaching hospital and Mosul general hospital as they represent the sole dialysis centers in Ninawa. The notes of patients on maintenance haemodialysis were studied by the researchers to collect data regarding the serology status (hepatitis B surface antigen, Anti- hepatitis C virus using ELISA technique), vaccination coverage with three doses of hepatitis B vaccine and data regarding age, gender &residence of these patients. Results: A total of 295 patients were included in this study.it is found that the prevalence of hepatitis B was 3.4% (10cases) and the prevalence of hepatitis C was 2.7% (8cases) We found that 6 of hepatitis B patients were male (3.9%) and 4 were female (2.8%) and 7 of hepatitis C patients were male (4.5%) and only one case was female (0.3%). All of hepatitis B&C patients were in the age above 15 years. The coverage with hepatitis B vaccine of all haemodialysis patients recruited in the study was only 47%. Conclusion &Recommendation: The prevalence of hepatitis B & C among haemodialysis patients in Ninawa is intermediate, in addition to low coverage of these patients with hepatitis B vaccination. So it is strongly recommended to increase coverage of all haemodialysis patients with Hepatitis B vaccine which is of vital importance in prevention of hepatitis B infection in this high risk group, In addition to strict adherence to infection control guidelines.

[Full Text Article] [Download Certificate]